| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 112.90B | 97.07B | 92.19B | 58.35B | 46.06B |
| Gross Profit | 23.78B | 19.14B | 15.88B | 8.90B | 7.84B |
| EBITDA | 13.45B | 10.86B | 8.14B | 3.57B | 3.67B |
| Net Income | 6.47B | 5.57B | 5.52B | 1.06B | 1.72B |
Balance Sheet | |||||
| Total Assets | 105.83B | 110.35B | 95.92B | 93.57B | 61.13B |
| Cash, Cash Equivalents and Short-Term Investments | 10.46B | 15.45B | 12.51B | 11.26B | 7.65B |
| Total Debt | 11.40B | 17.76B | 10.52B | 12.61B | 5.15B |
| Total Liabilities | 28.63B | 35.99B | 24.81B | 25.30B | 12.22B |
| Stockholders Equity | 77.20B | 72.89B | 71.11B | 68.26B | 48.90B |
Cash Flow | |||||
| Free Cash Flow | 10.72B | 6.07B | 4.87B | -2.21B | 1.42B |
| Operating Cash Flow | 10.76B | 8.93B | 6.66B | -1.63B | 2.18B |
| Investing Cash Flow | -6.10B | -8.98B | -822.00M | 4.61B | -651.00M |
| Financing Cash Flow | -9.64B | 2.99B | -4.59B | -3.68B | -2.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥50.18B | 10.44 | ― | 2.12% | 6.02% | 101.02% | |
71 Outperform | ¥11.93B | 4.34 | ― | 1.91% | 1.42% | 29.11% | |
69 Neutral | ¥31.59B | 9.94 | ― | 2.84% | 1.00% | 15.35% | |
68 Neutral | ¥83.87B | 13.16 | ― | 3.90% | 16.31% | 16.48% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥102.39B | 25.97 | ― | 3.97% | 0.74% | -35.11% |